Wenwen Lei

机构：China Pharmaceutical University · ORCID：0000-0003-2532-0783

发表论文 88 篇 · 总被引 2372 次 · h-index 28

代表论文

• Low levels of neutralizing antibodies against XBB Omicron subvariants after BA.5 infection (2023 · Signal Transduction and Targeted Therapy · 被引 50)
• Two pan-SARS-CoV-2 nanobodies and their multivalent derivatives effectively prevent Omicron infections in mice (2023 · Cell Reports Medicine · 被引 49)
• A novel mRNA vaccine, SYS6006, against SARS-CoV-2 (2023 · Frontiers in Immunology · 被引 37)
• Rational design of an influenza-COVID-19 chimeric protective vaccine with HA-stalk and S-RBD (2023 · Emerging Microbes & Infections · 被引 32)
• A pan-coronavirus peptide inhibitor prevents SARS-CoV-2 infection in mice by intranasal delivery (2023 · Science China Life Sciences · 被引 26)
• Immune response and homeostasis mechanism following administration of BBIBP-CorV SARS-CoV-2 inactivated vaccine (2022 · The Innovation · 被引 20)